论文部分内容阅读
目的探讨巴曲酶与银杏达莫联合治疗脑梗死的疗效观察。方法 90例脑梗死患者,随机分为治疗组和对照组,各45例。对照组采用银杏达莫进行治疗,治疗组采用巴曲酶与银杏达莫联合用药进行治疗,临床观察对比两组患者治疗前后的神经功能损伤程度评分。结果治疗后,治疗组患者的神经功能损伤程度评分为(14.25±6.76)分,对照组为(17.28±7.21)分,两组神经功能损伤程度评分相比于治疗前均发生明显下降,但是治疗组下降程度更加显著,实施治疗后,两组结果对比,差异具有统计学意义(P<0.05)。结论巴曲酶与银杏达莫联合用药治疗脑梗死患者有较好的临床效果,能够起到保护患者大脑的作用,值得在临床上推广应用。
Objective To investigate the curative effect of batroxobin and gingko-dipyridamole on cerebral infarction. Methods 90 patients with cerebral infarction were randomly divided into treatment group and control group, 45 cases in each group. The control group was treated with gingko-damo, and the treatment group was treated with batroxobin and gingko-damo combined. The clinical scores of the two groups were compared before and after treatment. Results After treatment, the score of neurological impairment in the treatment group was (14.25 ± 6.76) points and that in the control group (17.28 ± 7.21) points. The score of neurological impairment in both groups was significantly lower than that before treatment, but the treatment The degree of decline was more significant. After treatment, the difference between the two groups was statistically significant (P <0.05). Conclusion Batroxobin and ginkgo biloba combination therapy for patients with cerebral infarction has a good clinical effect, can play a role in protecting the brain of patients, it is worth to promote the clinical application.